Multiple Sclerosis Clinical Trials

Showing 2801-2820 of 2,839 trials

COMPLETEDPhase 1

Acupuncture to Reduce Symptoms of Advanced Colorectal Cancer

NCT00034034

This study investigates the effect of acupuncture in reducing symptom distress in adults with advanced colon cancer.

Colorectal Neoplasms

National Center for Complementary and Integrative Health (NCCIH)105 participantsStarted Jun 2002

Pittsburgh, Pennsylvania, United States

TERMINATEDPhase 1

Study Evaluating MST-997 in Advanced Malignant Solid Tumors

NCT00088647

The primary objective of this clinical research study is to evaluate the safety, tolerability, and maximum tolerated dose (MTD) of intravenous (IV) MST-997 formulated in Intralipid 20% administered on a weekly schedule to subjects with advanced malignant solid tumors.

Neoplasms

Wyeth is now a wholly owned subsidiary of Pfizer

New York, New York, United States • Cleveland, Ohio, United States • Nashville, Tennessee, United States

TERMINATEDPhase 2

Study Assessing Efficacy of ZARNESTRA™ Combined With Tamoxifen in Patients With Advanced or Metastatic Breast Cancer

NCT00210028

The purpose of this study is to evaluate the objective response rate when ZARNESTRA is added to treatment with tamoxifen

Breast Neoplasms

Institut Claudius Regaud40 participantsStarted Aug 2003

Bordeaux, France • Montpellier, France • Toulouse, France

COMPLETEDPhase 2

A Phase 2, Randomized, Open-Label Study Of Single Agent CI-1033 In Patients With Advanced Non-Small Cell Lung Cancer

NCT00050830

The purpose of study to determine the activity of CI 1033 against tumors in patients with advanced or metastatic NSCLC who have failed prior platinum-based combination chemotherapy. Another objective is to determine the safety of CI 1033.

Lung Neoplasms

Pfizer163 participantsStarted Jan 2003

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Birmingham, Alabama, United States +54 more locations

Acupuncture to Reduce Symptoms of Advanced Colorectal Cancer

Study Evaluating MST-997 in Advanced Malignant Solid Tumors

Study Assessing Efficacy of ZARNESTRA™ Combined With Tamoxifen in Patients With Advanced or Metastatic Breast Cancer

A Phase 2, Randomized, Open-Label Study Of Single Agent CI-1033 In Patients With Advanced Non-Small Cell Lung Cancer

Related Searches

Cetuximab & Concomitant-Boost Accelerated RT in Patients With Locally Advanced Oropharynx Squamous Cell Carcinoma.

The Efficacy and Safety of Escitalopram for Depression in Multiple Sclerosis

XENOX - Evaluation of the Efficacy of Xaliproden in Reducing the Neurotoxicity of the Oxaliplatin + 5-FU/LV Chemotherapy

Measuring Alterations of DNA in Human Blood

Meaning-Centered Psychotherapy in Advanced Cancer

Massage Therapy for Cancer-Related Fatigue

Yoga: Effect on Attention in Aging & Multiple Sclerosis

Omega-3 Fatty Acid Treatment in Multiple Sclerosis

A Phase 3 Trial of ALIMTA (LY231514, Pemetrexed) Plus GEMZAR Versus GEMZAR in Patients With Unresectable or Metastatic Cancer of the Pancreas.

Comparing 3 Schedules of Alimta Plus Gemzar

Phase 3 Study of LY353381 Vs Tamoxifen in Women With Locally Advanced or Metastatic Breast Cancer.

Effect of TroVax in Patients Having Colorectal Cancer With Liver Metastases Removed

Tezacitabine With or Without 5-Fluorouracil (5-FU) for Advanced Esophageal Cancer or Gastric Cancer

Short-Term Effects of Medicinal Cannabis Therapy on Spasticity in Multiple Sclerosis

Collaborative Ocular Melanoma Study (COMS)

Multicenter Study Differentiated Thyroid Carcinoma